A phase I study of cordycepin (NSC 63984) plus 2'-deoxycoformycin [pentostatin] (NSC 218321) in patients with refractory TdT [terminal deoxynucleotidyl transferase] positive leukaemia

Trial Profile

A phase I study of cordycepin (NSC 63984) plus 2'-deoxycoformycin [pentostatin] (NSC 218321) in patients with refractory TdT [terminal deoxynucleotidyl transferase] positive leukaemia

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jun 2012

At a glance

  • Drugs Cordycepin (Primary) ; Pentostatin (Primary)
  • Indications Acute lymphoblastic leukaemia; Chronic myeloid leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Nov 2007 Trial centres added.
    • 10 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top